Docusates

Oral
Constipation

Intestinal obstruction or undiagnosed abdominal symptoms; presence of abdominal pain, nausea, vomiting. Concomitant use with liquid paraffin.

Avoid prolonged use. Pregnancy and lactation.

Significant: Rectal bleeding.
Gastrointestinal disorders: Rarely, diarrhoea, nausea, abdominal cramps.
Skin and subcutaneous tissue disorders: Rarely, rash.

Potentially Fatal: May enhance gastrointestinal uptake of liquid paraffin.

Description:
Mechanism of Action: Docusate Ca is an anionic surfactant that has emulsifying and wetting properties. It reduces the surface tension of the oil-water interface of the stool leading to enhanced incorporation of water and fat, allowing for softening of the stool.
Onset: 12-72 hours.
Pharmacokinetics:
Absorption: Absorbed from the gastrointestinal tract.
Excretion: Via bile.

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 31407, Docusate calcium. https://pubchem.ncbi.nlm.nih.gov/compound/Docusate-calcium. Accessed Nov. 24, 2020.

Store between 15-30°C.

Laxatives, Purgatives

Anon. Docusate Salts. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 06/10/2020.

Anon. Docusate. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 06/10/2020.

Buckingham R (ed). Docusates. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 06/10/2020.

Kao Tin Capsule, Liquid Filled (Major Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 06/10/2020.

Stool Softener Capsule, Liquid Filled (Geri-Care Pharmaceutical Corp). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 10/11/2020.